← Back
$MYGN All transactions

MYRIAD GENETICS INC

A

$ Value

$0

Shares

105,785

Price

$0

Filed

May 1

Insider

Name

Verratti Mark

Title

Chief Operating Officer

CIK

0001517026

Roles

Officer

Transaction Details

Transaction Date

2025-04-30

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

105,785

Footnotes

The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026.

Filing Info

Accession No.

0001517026-25-000005

Form Type

4

Issuer CIK

0000899923

Verratti Mark's History

Date Ticker Type Value
2026-04-14 MYGN F $5K
2026-02-02 MYGN A $0
2025-09-21 MYGN F $8K
2025-04-30 MYGN A $0

Other Insiders at MYGN (90d)

Insider Bought Sold Last
Verratti Mark
Chief Operating Officer
2026-04-14
Haas Kevin Richard
Chief Technology Officer
2026-02-02
Muzzey Dale
Chief Scientific Officer
2026-04-14
Wheeler Benjamin Richard
Chief Financial Officer
2026-02-02